
Health Canada approves Pfizer-BioNTech’s updated COVID-19 vaccine for ages six months and older
Health Canada has granted authorization for Pfizer-BioNTech’s revised COVID-19 vaccine, extending its eligibility to individuals aged six months and older. Targeting Omicron XBB.1.5 Subvariant: This mRNA vaccine has been specifically tailored to address the Omicron XBB.1.5 […]